Navigation Links
Malaria, potato famine pathogen share surprising trait

Two wildly different pathogens ?one that infects vegetables, the other infecting humans - essentially use the same protein code to get their disease-causing proteins into the cells of their respective hosts.

That's what researchers from Ohio State and Northwestern universities report in a study published in the current issue of the journal PLoS Pathogens. The scientists were surprised to learn that the pathogen that causes malaria in humans and the microbe that caused the Irish potato famine use identical protein signals to start an infection.

"I don't think anyone expected this," said Sophien Kamoun, a study co-author and an associate professor of plant pathology at Ohio State's Ohio Agricultural Research and Development Center in Wooster. "These are very different pathogens, and we never realized that there might be some similarities between them."

Kamoun says not to worry ?there's no chance that the potato pathogen will jump to humans, nor is it likely that the malaria parasite will start infecting plants.

However, he said it's feasible to think that one day researchers could develop a drug with a dual purpose ?one that would stop both Plasmodium falciparum, which causes malaria, and Phytophthora infestans, the microbe that triggers late potato blight in vegetables including potatoes, soybeans and tomatoes.

"It sounds crazy, but it's not totally ridiculous to consider such a drug," said Kamoun, who is an expert on the Phytophthora group of pathogens. He conducted the study with lead author Kasturi Haldar, of Northwestern, and with colleagues from both Ohio State and Northwestern.

Each year, malaria kills more than one million people ?mostly young African children ?and Phytophthora pathogens devastate a wide range of food and commercial crops.

The researchers swapped a small sequence of proteins, called the leader sequence, in P. falciparum with the leader sequence of P. infestans. A leader sequence is a grou p of about 20 to 30 amino acids on a protein secreted by the parasite. This sequence contains instructions on how to enter, and therefore start infecting, a plant or animal cell.

In laboratory experiments, the researchers infected human red blood cells with the modified malarial pathogen.

Results showed that malaria proteins could just as effectively enter and infect a cell when it contained the P. infestans leader sequence instead of its own.

"Our findings show that very distinct microbes can share similar strategies for delivering toxic proteins to their targets," Kamoun said.

About a year and a half ago, Kamoun and his group at Ohio State read studies conducted by the Northwestern researchers that described the leader sequence of the malaria parasite. The similarity between this and the leader sequence of P. infestans was remarkable, he said.

"So we decided to collaborate and see if the sequences were not just similar, but also functionally the same," he said. "It turned out that they were. But although the mechanism of getting virulence proteins into a host cell is very similar, the infection-causing proteins that are delivered to a host are completely different."

To Kamoun's knowledge, this is the first paper to show that such dissimilar pathogens of this type - both are eukaryotic organisms ?share a remarkably similar trait. He and his colleagues aren't sure how to explain this phenomenon, as these pathogens belong to distinctly different evolutionary groups.


'"/>

Source:Ohio State University


Related biology news :

1. Researchers find gene that may be at root of potato blight
2. 15 generations of untrained jocks, couch potatoes show big physiological adaptations
3. Finding rewrites the evolutionary history of the origin of potatoes
4. Six million Africans face famine because of locusts, drought
5. Prenatal exposure to famine increases risk of schizophrenia
6. Researchers develop rapid diagnostic tool for pathogen identification
7. A new study examines how shared pathogens affect host populations
8. New lab technique identifies high levels of pathogens in therapy pool
9. Researchers uncover sequence of major rice pathogen
10. Edible bivalves as a source of human pathogens: signals between vibrios and the bivalve host.
11. Tagging pathogens with synthetic DNA barcodes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... but it also plays a fundamental part in enabling and ...
(Date:4/15/2016)... , April 15, 2016  A new partnership ... more accurate underwriting decisions in a fraction of ... competitively priced and high-value life insurance policies to ... With Force Diagnostics, rapid testing (A1C, ... data readings (blood pressure, weight, pulse, BMI, and ...
(Date:3/31/2016)... 31, 2016  Genomics firm Nabsys has completed a ... Barrett Bready , M.D., who returned to the company ... technical leadership team, including Chief Technology Officer, John ... Steve Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016  Global demand ... 4.6 percent through 2020 to $7.2 billion.  This ... and beverages, cleaning products, biofuel production, animal feed, ... biotechnology, diagnostics, and biocatalysts). Food and beverages will ... driven by increasing consumption of products containing enzymes ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created ... services and solutions to the healthcare market. The company's primary focus is on ... sales and marketing strategies that are necessary to help companies efficiently bring their ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
Breaking Biology Technology: